{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:16:43Z","timestamp":1788405403903,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clinthera.2015.03.018","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T14:01:53Z","timestamp":1428760913000},"page":"1228-1234","source":"Crossref","is-referenced-by-count":16,"title":["Gastrointestinal Events Among Patients Initiating Osteoporosis Therapy: A Retrospective Administrative Claims Database Analysis"],"prefix":"10.1016","volume":"37","author":[{"given":"Ankita","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel S.","family":"Siris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Po","family":"Steve Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.03.018_bib1","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinthera.2015.03.018_bib2","first-page":"1","article-title":"Osteoporosis or low bone mass at the femur neck or lumbar spine in older adults: United States, 2005-2008","volume":"93","author":"Looker","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.clinthera.2015.03.018_bib3","doi-asserted-by":"crossref","unstructured":"Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010;17:25-54; quiz 55-56.","DOI":"10.1097\/gme.0b013e3181c617e6"},{"issue":"suppl 3","key":"10.1016\/j.clinthera.2015.03.018_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.16.S3.1","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis","volume":"16","author":"Watts","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2015.03.018_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-011-1694-y","article-title":"The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008","volume":"23","author":"Dawson-Hughes","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib6","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1023\/A:1016495221567","article-title":"What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates","volume":"47","author":"Graham","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2015.03.018_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4065\/77.10.1031","article-title":"Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?","volume":"77","author":"Cryer","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.clinthera.2015.03.018_bib8","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clinthera.2015.03.018_bib9","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2015.03.018_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2006.01.011","article-title":"Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety","volume":"54","author":"Epstein","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.clinthera.2015.03.018_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JCD:6:1:45","article-title":"Bone density changes with once weekly risedronate in postmenopausal women","volume":"6","author":"Delaney","year":"2003","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.clinthera.2015.03.018_bib12","first-page":"S207","article-title":"Incidence of gastrointestinal events among bisphosphonate patients in an observational setting","volume":"10","author":"Miller","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2015.03.018_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1345\/aph.1L555","article-title":"Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate","volume":"43","author":"Blumentals","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2015.03.018_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2015.03.018_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2006.01.002","article-title":"Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis","volume":"28","author":"Penning-van Beest","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2015.03.018_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2015.03.018_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1745-7599.2008.00316.x","article-title":"The prevalence and pattern of gastroesophageal reflux symptoms in perimenopausal and menopausal women","volume":"20","author":"Infantino","year":"2008","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.clinthera.2015.03.018_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","article-title":"Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study","volume":"3","author":"Camilleri","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2015.03.018_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00223-009-9323-x","article-title":"Gastric and esophagus events before and during treatment of osteoporosis","volume":"86","author":"Vestergaard","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00198-009-0871-8","article-title":"Comparative gastrointestinal safety of weekly oral bisphosphonates","volume":"20","author":"Cadarette","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.2005.02378.x","article-title":"Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use","volume":"21","author":"Cryer","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2015.03.018_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00198-002-1370-3","article-title":"Tolerability and compliance with risedronate in clinical practice","volume":"14","author":"Hamilton","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0149-2918(04)90023-9","article-title":"Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study","volume":"26","author":"Turbi","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2015.03.018_bib24","first-page":"76","article-title":"Compliance with alendronate 10 treatment in elderly women with postmenopausal osteoporosis","volume":"60","author":"Sewerynek","year":"2009","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.clinthera.2015.03.018_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00296-009-0940-5","article-title":"Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis","volume":"30","author":"Ringe","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/147323000903700430","article-title":"Preferences of patients with post-menopausal osteoporosis treated with bisphosphonates--the VIVA II study","volume":"37","author":"Payer","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2015.03.018_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00223-010-9401-0","article-title":"Risk of upper gastrointestinal tract events in risedronate users switched to alendronate","volume":"87","author":"Ralston","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinthera.2015.03.018_bib28","first-page":"233","article-title":"Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases","volume":"6","author":"Anastasilakis","year":"2007","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.clinthera.2015.03.018_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.162.8.936","article-title":"Gastric and duodenal safety of daily alendronate","volume":"162","author":"Donahue","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2015.03.018_bib30","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-2036.2009.03989.x","article-title":"Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study","volume":"29","author":"Etminan","year":"2009","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T15:50:40Z","timestamp":1537717840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0149291815001605"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.03.018","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}